The interaction between human enteroviruses and type I IFN signaling pathway

References

• Abe Y, Fujii K, Nagata N, et al. (2012). The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J Virol 86:185–94
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell 124:783–801
   PubMed Web of Science ®Google Scholar
• Arya SC. (2000). Antiviral therapy for neurological manifestations of enterovirus 71 infection. Clin Infect Dis 30:988
   PubMed Web of Science ®Google Scholar
• Barral PM, Morrison JM, Drahos J, et al. (2007). MDA-5 is cleaved in poliovirus-infected cells. J Virol 81:3677–84
   PubMed Web of Science ®Google Scholar
• Barral PM, Sarkar D, Fisher PB, Racaniello VR. (2009). RIG-I is cleaved during picornavirus infection. Virology 391:171–6
   PubMed Web of Science ®Google Scholar
• Chang LY, King CC, Hsu KH, et al. (2002). Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 109:e88
   PubMed Web of Science ®Google Scholar
• Chang LY, Lin TY, Huang YC, et al. (1999). Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 18:1092–6
   PubMed Web of Science ®Google Scholar
• Choe SS, Dodd DA, Kirkegaard K. (2005). Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337:18–29
   Google Scholar
• Chong CY, Chan KP, Shah VA, et al. (2003). Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr 92:1163–9
   PubMed Web of Science ®Google Scholar
• Desai SY, Sen GC. (1997). Effects of varying lengths of double-stranded RNA on binding and activation of 2'-5'-oligoadenylate synthetase. J Interferon Cytokine Res 17:531–6
   PubMed Web of Science ®Google Scholar
• Didcock L, Young DF, Goodbourn S, Randall RE. (1999). The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–33
   PubMedGoogle Scholar
• Dodd DA, Giddings TH JR, Kirkegaard K. (2001). Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J Virol 75:8158–65
   PubMed Web of Science ®Google Scholar
• Dong B, Niwa M, Walter P, Silverman RH. (2001). Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p. RNA 7:361–73
   PubMed Web of Science ®Google Scholar
• Etchison D, Milburn SC, Edery I, et al. (1982). Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220 000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257:14806–10
   PubMed Web of Science ®Google Scholar
• Fowlkes AL, Honarmand S, Glaser C, et al. (2008). Enterovirus-associated encephalitis in the California encephalitis project, 1998–2005. J Infect Dis 198:1685–91
   PubMed Web of Science ®Google Scholar
• Frieman M, Heise M, Baric R. (2008). SARS coronavirus and innate immunity. Virus Res 133:101–12
   PubMed Web of Science ®Google Scholar
• Gauzzi MC, Velazquez L, Mckendry R, et al. (1996). Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem 271:20494–500
   PubMed Web of Science ®Google Scholar
• Goodbourn S, Didcock L, Randall RE. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341–64
   PubMed Web of Science ®Google Scholar
• Gotoh B, Komatsu T, Takeuchi K, Yokoo J. (2002). Paramyxovirus strategies for evading the interferon response. Rev Med Virol 12:337–57
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Fujisawa H, Sakai K, et al. (2008). Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. Emerg Infect Dis 14:828–30
   PubMed Web of Science ®Google Scholar
• Han JQ, Townsend HL, Jha BK, et al. (2007). A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J Virol 81:5561–72
   PubMed Web of Science ®Google Scholar
• Hardy MP, Owczarek CM, Jermiin LS, et al. (2004). Characterization of the type I interferon locus and identification of novel genes. Genomics 84:331–45
   PubMed Web of Science ®Google Scholar
• Heim MH. (1999). The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct Res 19:75–120
   PubMed Web of Science ®Google Scholar
• Ho BC, Yu SL, Chen JJ, et al. (2011). Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9:58–69
   PubMed Web of Science ®Google Scholar
• Hu YF, Yang F, Du J, et al. (2011). Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A. J Clin Microbiol 49:2426–34
   PubMed Web of Science ®Google Scholar
• Huang WT, Lee PI, Chang LY, et al. (2011). Epidemic pleurodynia caused by coxsackievirus B3 at a medical center in northern Taiwan. J Microbiol Immunol Infect 43:515–8
   Google Scholar
• Hultcrantz M, Huhn MH, Wolf M, et al. (2007). Interferons induce an antiviral state in human pancreatic islet cells. Virology 367:92–101
   PubMed Web of Science ®Google Scholar
• Ida-Hosonuma M, Iwasaki T, Yoshikawa T, et al. (2005). The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 79:4460–9
   PubMed Web of Science ®Google Scholar
• Isaacs A, Lindenmann J. (1957). Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258–67
   PubMed Web of Science ®Google Scholar
• Isaacs A, Lindenmann J, Valentine RC. (1957). Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci 147:268–73
   PubMed Web of Science ®Google Scholar
• Iwamura T, Yoneyama M, Yamaguchi K, et al. (2001). Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6:375–88
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Mikamo-Satoh E, et al. (2008). Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601–10
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Sato S, et al. (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–5
   PubMed Web of Science ®Google Scholar
• Kerkmann M, Rothenfusser S, Hornung V, et al. (2003). Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 170:4465–74
   PubMed Web of Science ®Google Scholar
• Klingel K, Hohenadl C, Canu A, et al. (1992). Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 89:314–8
   PubMed Web of Science ®Google Scholar
• Komatsu H, Shimizu Y, Takeuchi Y, et al. (1999). Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol 20:17–23
   PubMed Web of Science ®Google Scholar
• Lei X, Liu X, Ma Y, et al. (2010). The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84:8051–61
   PubMed Web of Science ®Google Scholar
• Lei X, Sun Z, Liu X, et al. (2011). Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 85:8811–8
   PubMed Web of Science ®Google Scholar
• Lei X, Xiao X, Xue Q, et al. (2013). Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol 87:1690–8
   PubMed Web of Science ®Google Scholar
• Liu J, Huangfu WC, Kumar KG, et al. (2009). Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 5:72–83
   PubMed Web of Science ®Google Scholar
• Liu ML, Lee YP, Wang YF, et al. (2005). Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86:3263–9
   PubMed Web of Science ®Google Scholar
• Lu J, Yi LN, Zhao J, et al. (2012). Enterovirus 71 Disrupts Interferon Signaling by Reducing the Level of Interferon Receptor 1. Journal of Virology 86:3767–76
   PubMed Web of Science ®Google Scholar
• Marie I, Durbin JE, Levy DE. (1998). Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 17:6660–9
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Funami K, Tanabe M, et al. (2003). Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171:3154–62
   PubMed Web of Science ®Google Scholar
• Morrison JM, Racaniello VR. (2009). Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J Virol 83:4412–22
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Morosky SA, Delorme-Axford E, et al. (2011). The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311
   PubMed Web of Science ®Google Scholar
• Novick D, Cohen B, Tal N, Rubinstein M. (1995). Soluble and membrane-anchored forms of the human IFN-alpha/beta receptor. J Leukoc Biol 57:712–8
   PubMed Web of Science ®Google Scholar
• Oberste MS, Maher K, Pallansch MA. (2002). Molecular phylogeny and proposed classification of the simian picornaviruses. J Virol 76:1244–51
   PubMed Web of Science ®Google Scholar
• Oberste MS, Pallansch MA. (2003). Establishing evidence for enterovirus infection in chronic disease. Ann N Y Acad Sci 1005:23–31
   PubMed Web of Science ®Google Scholar
• Ohka S, Igarashi H, Nagata N, et al. (2007). Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol 81:7902–12
   PubMed Web of Science ®Google Scholar
• Perera D, Shimizu H, Yoshida H, et al. (2010). A comparison of the VP1, VP2, and VP4 regions for molecular typing of human enteroviruses. J Med Virol 82:649–57
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Mclinn S, Rotbart HA, et al. (1998). Clinical and economic impact of enterovirus illness in private pediatric practice. Pediatrics 102:1126–34
   PubMed Web of Science ®Google Scholar
• Prakash A, Smith E, Lee CK, Levy DE. (2005). Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 280:18651–7
   PubMed Web of Science ®Google Scholar
• Rebsamen M, Meylan E, Curran J, Tschopp J. (2008). The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ 15:1804–11
   PubMed Web of Science ®Google Scholar
• Riad A, Westermann D, Zietsch C, et al. (2011). TRIF Is a Critical Survival Factor in Viral Cardiomyopathy. J Immunol 186:2561–70
   PubMed Web of Science ®Google Scholar
• Richer MJ, Lavallee DJ, Shanina I, Horwitz MS. (2009). Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 4:e4127
   PubMed Web of Science ®Google Scholar
• Roivainen M, Klingel K. (2009). Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 52:995–6
   PubMed Web of Science ®Google Scholar
• Samuel CE. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14:778–809 (table of contents)
   PubMed Web of Science ®Google Scholar
• Sato M, Suemori H, Hata N, et al. (2000). Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539–48
   PubMed Web of Science ®Google Scholar
• Satoh M, Akatsu T, Ishikawa Y, et al. (2007). Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy. Am Heart J 154:581–8
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, et al. (2010). Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778–90
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. (2003). Toll-like receptors. Annu Rev Immunol 21:335–76
   PubMed Web of Science ®Google Scholar
• Tatrai E, Hartyanszky I JR, Laszik A, et al. (2010). The role of viral infections in the development of dilated cardiomyopathy. Pathol Oncol Res 17:229–35
   PubMed Web of Science ®Google Scholar
• Townsend HL, Jha BK, Silverman RH, Barton DJ. (2008). A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease L. RNA Biol 5:263–72
   PubMed Web of Science ®Google Scholar
• Triantafilou K, Orthopoulos G, Vakakis E, et al. (2005). Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 7:1117–26
   PubMed Web of Science ®Google Scholar
• Tsai HP, Huang SW, Wu FL, et al. (2011). An echovirus 18-associated outbreak of aseptic meningitis in Taiwan: epidemiology and diagnostic and genetic aspects. J Med Microbiol 60:1360–5
   PubMed Web of Science ®Google Scholar
• Wang B, Xi X, Lei X, et al. (2013). Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231
   Web of Science ®Google Scholar
• Wang JP, Cerny A, Asher DR, et al. (2010). MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol 84:254–60
   PubMed Web of Science ®Google Scholar
• Wang YX, Da Cunha V, Vincelette J, et al. (2007). Antiviral and myocyte protective effects of murine interferon-beta and -alpha 2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. Am J Physiol Heart Circulat Physiol 293:H69–76
   PubMed Web of Science ®Google Scholar
• Wathelet MG, Lin CH, Parekh BS, et al. (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1:507–18
   PubMed Web of Science ®Google Scholar
• Wessely R, Klingel K, Knowlton KU, KANDOLF R. (2001). Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756–61
   PubMed Web of Science ®Google Scholar
• Xiang Z, Gonzalez R, Wang Z, et al. (2012). Coxsackievirus A21, enterovirus 68, and acute respiratory tract infection, China. Emerg Infect Dis 18:821–4
   PubMed Web of Science ®Google Scholar
• Yi L, He Y, Chen Y, et al. (2011a). Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther 16:51–8
   PubMed Web of Science ®Google Scholar
• Yi L, Lu J, Kung HF, He ML. (2011b). The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37:313–27
   PubMed Web of Science ®Google Scholar
• Yozwiak NL, Skewes-Cox P, Gordon A, et al. (2010). Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol 84:9047–58
   PubMed Web of Science ®Google Scholar